Synergistic Antibacterial Effect of Silver Nanoparticles Combined with Ineffective Antibiotics on Drug Resistant Salmonella typhimurium DT104

REFERENCES

• Wax RG, Lewis K, Salyers AA, Taber H. Bacterial Resistance to Antimicrobials, Second Edition edn. Boca Raton, FL: CRC Press; 2012.
   Google Scholar
• WHO. Antimicrobial resistance: global report on surveillance 2014. Geneva, Switzerland: World Health Organization; 2014.
   Google Scholar
• Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature 2000, 406:775–781.
   PubMed Web of Science ®Google Scholar
• Rice LB. The clinical consequences of antimicrobial resistance. Curr Opin Microbiol 2009, 12:476–481.
   PubMed Web of Science ®Google Scholar
• Dasari TPS, Deng H, McShan D, Yu H. Nanosilver-Based Antibacterial Agents for Food Safety. In: Food Poisoning: Outbreaks, Bacterial Sources and Adverse Health Effects. Edited by Ray PC: Nova Science Publishing; 2014: Chapter 2.
   Google Scholar
• Boucher HW, Talbot GH, Bradley JS, Edwards Jr. JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1–12.
   PubMed Web of Science ®Google Scholar
• Dechet AM, Scallan E, Gensheimer K, Hoekstra R, Gunderman-King J, Lockett J, Wrigley D, Chege W, Sobel J. Outbreak of multidrug-resistant Salmonella enterica serotype typhimurium definitive type 104 infection linked to commercial ground beef, Northeastern United States, 2003-2004. Clin Infect Dis 2006, 42(6):747–752.
   PubMed Web of Science ®Google Scholar
• Mather AE, Reid SW, Maskell DJ, Parkhill J, Fookes MC, Harris SR, Brown DJ, Coia JE, Mulvey MR, Gilmour MW et al. Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts. Science 2013, 341(6153):1514–1517.
   PubMed Web of Science ®Google Scholar
• Poppe C, Smart N, Khakhria R, Johnson W, Spika J, Prescott J. Salmonella typhimurium DT104: a virulent and drug-resistant pathogen. Can Vet J 1998, 39(9):559–565.
   PubMed Web of Science ®Google Scholar
• Threlfall EJ. Epidemic Salmonella typhimurium DT104 - A truly international multiresistant clone. J Antimicrob Chemother 2000, 46(1):7–10.
   PubMed Web of Science ®Google Scholar
• Taylor PW, Stapleton PD, Luzio JP. New ways to treat bacterial infections. Drug Discov Today 2002, 21(7):1086–1091.
   Web of Science ®Google Scholar
• Zhang Y, Dasari TPS, Deng H, Yu H. Antimicrobial Activity of Gold Nanoparticles and Gold Ions. J Environ Sci Health Part C: Environ Carcinog Ecotoxicol Revs 2015, 33(3).
   Google Scholar
• Daima HK, Selvakannan P, Shukla R, Bhargava SK, Bansal V. Fine-tuning the antimicrobial profile of biocompatible gold nanoparticles by sequential surface functionalization using polyoxometalates and lysine. Plos One 2013, 8:e79676.
   PubMed Web of Science ®Google Scholar
• He W, Wamer W, Fu PP, Yin JJ. Enzyme-mimetic effects of gold@platinum nanorods on the antioxidant activity. J Environ Sci Health, Part C: Environ Carcinog Ecotoxicol Revs 2014, 32:186–211.
   PubMed Web of Science ®Google Scholar
• Fu PP, Xia Q, Hwang H-M, Ray PC, Yu H. Mechanism of nanotoxicity - Generation of reactive oxygen species. J Food Drug Anal 2014, 22:64–75.
   PubMed Web of Science ®Google Scholar
• Ray PC, Yu H, Fu PP. Nano gold based sensing of environmental toxin: excitement and challenges. J Environ Sci Health, Part C: Environ Carcinog Ecotoxicol Revs 2011, 29:52–89.
   Web of Science ®Google Scholar
• Naqvi SZH, Kiran U, Ali MI, Jamal A, Hameed A, Ahmed S, Ali N. Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria. Int J Nanomedicine 2013, 8:3187–3195.
   PubMed Web of Science ®Google Scholar
• Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Coll Interf Sci 2004, 275:177–182.
   PubMed Web of Science ®Google Scholar
• Singh M, S. S, Prasad S, Gambhir S. Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Dig J Nanomat Biostruct 2008, 3(3):115–122.
   Web of Science ®Google Scholar
• Chen X, Schluesener HJ. Nanosilver: A nanoproduct in medical application. Toxicol Lett 2008, 176(1):1–12.
   PubMed Web of Science ®Google Scholar
• Sotiriou GA, Pratsinis SE. Antibacterial Activity of Nanosilver Ions and Particles. Environ Sci Technol 2010, 44(14):5649–5654.
   PubMed Web of Science ®Google Scholar
• Faya AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine 2010, 6(1):103–109.
   PubMed Web of Science ®Google Scholar
• Guzman M, Dille J, Godet S. Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria. Nanomed: Nanotech Biol Med 2012, 8(1):37–45.
   PubMed Web of Science ®Google Scholar
• Kvitek L, Vanickova M, Panacek A, Soukupova J, Dittrich M, Valentova E, Prucek R, Bancirova M, Milde D, Zboril R. Initial Study on the Toxicity of Silver Nanoparticles (NPs) against Paramecium caudatum. J Phys Chem C 2009, 113(11):4296–4300.
   Web of Science ®Google Scholar
• Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomed: Nanotech Biol Med 2007, 3(2):168–171.
   PubMed Web of Science ®Google Scholar
• McShan D, Ray PC, Yu H. Molecular toxicity mechanism of nanosilver. J Food Drug Anal 2014, 22(1):116–127.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Mukherjee P, Senapati S, Mandal D, Khan MI, Kumar R, Sastry M. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Coll Surf B Biointerf 2003, 28(4):313–318.
   Web of Science ®Google Scholar
• Mala R, Arunachalam P, Sivasankari M. Synergistic bactericidal activity of silver nanoparticles and ciprofloxacin against phytopathogens. J Cell Tissue Res 2012, 12(2):3249–3254.
   Google Scholar
• Li P, Li J, Wu C, Wu Q, Li J. Synergistic effect of B-lactam antibiotic combined with silver nanoparticles. Nanotechnology 2005, 16:1912–1917.
   Web of Science ®Google Scholar
• Morones JR, Camacho A, Holt K, Ramirez JT, Yacaman MJ. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346–2353.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Patil S, Ahire M, Kitture R, Kale S, Pardesi K, Cameotra SS, Bellare J, Dhavale DD, Jabgunde A et al. Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents. Int J Nanomed 2012, 7:483–496.
   PubMed Web of Science ®Google Scholar
• He D, Dorantes-Aranda JJ, Waite TD. Silver nanoparticle algae interactions: oxidative dissolution, reactive oxygen species generation and synergistic toxic effects. Environ Sci Technol 2012, 46:8731–8738.
   PubMed Web of Science ®Google Scholar
• Hwang I, Hwang J, Choi H, Kim K, Lee D. Synergistic effect with silver nanoparticles and its involved mechanisms. J Med Microbiol 2012, 61 1719–1726.
   PubMed Web of Science ®Google Scholar
• Ruden S, Hilpert K, Berditsch M, Wadhwani P, Ulrich AS. Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial Peptides. Antimicrob Agents Chemother 2009, 53(8):3538–3540.
   PubMed Web of Science ®Google Scholar
• Allahverdiyey A, Kon K, Abamor E, Bairova M, Rafailovich M. Coping with antibiotics resistance: combining nanoparticles with antibiotics and other antimicrobial agents. Expert Rev Anti Infect Ther 2011, 9(11):1035–1052.
   PubMed Web of Science ®Google Scholar
• Basavaraja S, Balaji D, Lagashetty A, Rajasab A, Venkataraman A. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium semitectum. Mater Res Bull 2008, 43(5):1164–1170.
   Web of Science ®Google Scholar
• Muthiah B, Stanley S. In vivo toxicity assessment of silver nanoparticles synthesized from marine sponges (Haliclona implexiformis). J Pharm Res 2010, 3(10):2552–2554.
   Google Scholar
• Chopra I, Roberts M. Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance. Microbiol Mol Biol Rev 2001, 65(2):232–260.
   PubMed Web of Science ®Google Scholar
• Kaul M, Pilch DS. Thermodynamics of Aminoglycoside-rRNA Recognition: The Binding of Neomycin-Class Aminoglycosides to the A Site of 16S rRNA. Biochemistry 2002, 41:7695–7706.
   PubMed Web of Science ®Google Scholar
• Dufrenoy J, Pratt R. Cytochemical Mechanisms of Penicillin Action V. Comparative Effects of Ribonuclease, Cobra Venom, and Penicillin on Susceptible Bacteria. J Bacteriol 1948, 55(4):525–530.
   Web of Science ®Google Scholar
• Yocum RR, Rasmussen JR, Strominger JL. The Mechanism of Action of Penicillin: Penicillin acylates the active site of bacillus stearothermophzlus d-alanine carboxypeptidase. J Biol Chem 1980, 255(9):3977–3986.
   PubMed Web of Science ®Google Scholar
• Turkevich J, Stevenson PC, Hiller S. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951, 11:55–75.
   Google Scholar
• McShan D, Yu H. DNA damage in human skin keratinocytes caused by multiwalled carbon nanotubes with carboxylate functionalization. Toxicol Ind Health 2012, Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Connell SR, Tracz DM, Nierhausm KH, Taylor DE. Ribosomal Protection Proteins and Their Mechanism of Tetracycline Resistance. Antimicrob Agents Chemother 2003, 47(12):3675–3681.
   PubMed Web of Science ®Google Scholar
• Udumula V, Ham YW, Fosso MY, Chan KY, Rai R, Zhang J, Li J, Chang CW. Investigation of antibacterial mode of action for traditional and amphiphilic aminoglycosides. Bioorg Med Chem Lett 2013, 23(6):1671–1675.
   PubMed Web of Science ®Google Scholar
• Khan SS, Srivatsan P, Vaishnavi N, Mukherjee A, Chandrasekaran N. Interaction of silver nanoparticles (SNPs) with bacterial extracellular proteins (ECPs) and its adsorption isotherms and kinetics. J Hazard Mater 2011, 192(1):299–306.
   PubMed Web of Science ®Google Scholar
• Reidy B, Haase A, Luch A, Dawson KA, Lynch I. Mechanisms of silver nanoparticle release, transformation and toxicity: a critical review of current knowledge and recommendations for future studies and applications. Materials 2013, 6:2295–2350.
   PubMed Web of Science ®Google Scholar
• Wigginton NS, de Titta A, Piccapietra F, Dobias J, Nesatyy VJ, Suter MJF, Bernier-Latmani R. Binding of Silver Nanoparticles to Bacterial Proteins Depends on Surface Modifications and Inhibits Enzymatic Activity. Environ Sci Technol 2010, 44(6):2163–2168.
   PubMed Web of Science ®Google Scholar
• Baruwati B, Simmons SO, Varma RS, Veronesi B. “Green” synthesized and coated nanosilver alters the membrane permeability of barrier (intestinal, brain endothelial) cells and stimulates oxidative stress pathways in neurons. ACS Sustain Chem Eng 2013, 1:753–759.
   Web of Science ®Google Scholar